(Press-News.org) Weill Cornell Medicine has received a five-year, $12.4 million grant from the National Cancer Institute, part of the National Institutes of Health, for an extensive program of basic and translational research on the biology of diffuse large B-cell lymphoma (DLBCL), the most common form of lymphoma.
The investigator-initiated Program Project grant, led by Dr. Leandro Cerchietti, the Richard A. Stratton Associate Professor in Hematology and Oncology at Weill Cornell Medicine, and Dr. Christopher Flowers, professor and chair of the Department of Lymphoma and Myeloma at The University of Texas MD Anderson Cancer Center, is meant to support a collaborative, multi-faceted effort towards a major biomedical research goal.
DLBCL represents a significant challenge for cancer biologists because about 40% of patients either don’t respond well to initial chemotherapy or end up relapsing. Response rates also can vary dramatically among different DLBCL subtypes. Researchers expect that the development of significantly better treatments will require a more comprehensive understanding of the complex processes that trigger and sustain the disease.
DLBCL cells are known to originate from antibody-producing B cells residing in lymph node structures called germinal centers. As part of the normal immune response, for example to fight infection, B cells gather in these centers, briefly proliferating and mutating their antibody-coding genes to diversify their ability to bind to antigens. This ultimately allows the antibody response to effectively neutralize its targets. But B cells in this high-mutation state are especially vulnerable to cancerous changes. The collective work of lymphoma scientists has shown in prior studies that lymphoma-driving gene mutations often work by reprogramming B cells so that they linger in germinal centers, eventually accumulating full malignancy.
As part of the newly funded research program, the researchers intend to reveal this lymphomagenesis process in unprecedented detail, showing how different combinations of gene mutations and interactions with partner immune cells can combine to turn germinal center B cells into different DLBCL subtypes. They will focus strongly on the role of chromatin—the overall packaging of DNA, which programs gene activity and gives cells their basic identity—as the key integrator and modulator of these interactions in germinal center B and DLBCL cells.
The laboratories of Drs. Ari Melnick, Steven Josefowicz, Ethel Cesarman, Giorgio Inghirami, Sanjay Patel. John Leonard and Christopher Mason at Weill Cornell Medicine will collaborate on the various projects funded by the grant, These investigators, as well as Dr. Cerchietti, are members of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. Dr. Michael Green, an associate professor in the Division of Cancer Medicine at MD Anderson will contribute his laboratory’s expertise to the projects as well.
The researchers expect their progress in understanding DLBCL origins to illuminate vulnerabilities in these cancers that can be exploited with new and precise treatments—with emphasis on milder, non-chemotherapy treatments that will be more tolerable, especially for older patients. For example, Dr. Cerchietti and colleagues aim to develop methods for reprogramming lymph node-resident T cells so that they attack DLBCL cells.
Dr. Cerchietti noted that he and his colleagues will be able to make use of the unique collections of patient tumor samples and novel preclinical models of lymphoma that have been developed over years of collaboration by the investigators participating in this grant under the scientific umbrella of the Weill Cornell Medicine Lymphoma Program, as well as from the MD Anderson team.
“This generous grant will allow us to make real advances in understanding lymphoma biology, but it is built on substantial foundations we’ve laid in recent years with our collaborative basic and preclinical research, as well as clinical trials,” Dr. Cerchietti said.
END
NIH grant will support fundamental lymphoma research
2024-08-15
ELSE PRESS RELEASES FROM THIS DATE:
Mind the Gap: NIH awards UMass researcher $1.9 million to study closing cellular gaps
2024-08-15
The National Institute of General Medical Sciences, a branch of the National Institutes of Health (NIH), has awarded Yubing Sun, associate professor of mechanical and industrial engineering at the University of Massachusetts Amherst, a $1.9 million Maximizing Investigators’ Research Award to support the exploration of the fundamental principles behind the process that close gaps caused by injury or growth between cells. This research has the potential to push forward advances in our understanding of wound healing, cellular regeneration therapies and embryonic development.
The gaps ...
Surprise Finding in study of environmental bacteria could advance search for better antibiotics
2024-08-15
**EMBARGOED UNTIL THURSDAY, AUG. 15, AT 9 A.M. ET**
In what they labeled a “surprising” finding, Johns Hopkins Medicine researchers studying bacteria from freshwater lakes and soil say they have determined a protein’s essential role in maintaining the germ’s shape. Because the integrity of a bacterial cell’s “envelope” or enclosure is key to its survival, the finding could advance the search for new and better antibiotics.
The research, described August 15 in the journal mBio, suggests that loss of a protein ...
A genetic analysis of lyme disease could improve diagnosis and treatment
2024-08-15
A genetic analysis of Lyme disease bacteria may pave the way for improved diagnosis, treatment and prevention of the tick-borne ailment.
By mapping the complete genetic makeup of 47 strains of Lyme disease-causing bacteria from around the world, the international team has created a powerful resource for identifying the specific bacterial strains that infect patients. Researchers said this could enable more accurate diagnostic tests and treatments tailored to the exact type or types of bacteria causing each patient’s illness.
"This comprehensive, high-quality sequencing investigation of Lyme disease and related bacteria provides the foundation to propel the field forward,” ...
Scientists map DNA of Lyme disease bacteria
2024-08-15
A team led by CUNY Graduate Center biologists has produced a genetic analysis of Lyme disease bacteria that may pave the way for improved diagnosis, treatment, and prevention of the tick-borne ailment.
Weigang Qiu, a professor of Biology at the CUNY Graduate Center and Hunter College, and an international team including lead author Saymon Akther, a former CUNY Graduate Center Biology Ph.D. student, mapped the complete genetic makeup of 47 strains of Lyme disease-related bacteria from around the world, creating a powerful tool for identifying the bacterial strains that ...
Researchers awarded $2.8M federal grant to study potential treatment of Sudden Infant Death Syndrome
2024-08-15
CLEVELAND—More than 3,400 Sudden Unexpected Infant Deaths are reported annually in the United States, making it the country’s biggest cause of death of infants from 1 month to 1 year old, according to the Centers for Disease Control and Prevention (CDC).
Most of these deaths are classified as Sudden Infant Death Syndrome (SIDS), a disorder with numerous, unexplained causes that have plagued researchers for decades.
Now, with a new five-year, $2.8 million grant from the National Institutes of Health, researchers from Case Western Reserve University and University Hospitals Rainbow Babies ...
Blood pressure levels impacted by chronic occupational noise exposure
2024-08-15
Noise exposure is a known occupational hazard in some jobs, particularly for hearing loss, physical and psychological stress, and reduced concentration. A new study presented at the ACC Asia 2024 conference found in adult power loom weavers, chronic noise exposure not only increased their blood pressure overall, but also each year of exposure increased their odds of having high blood pressure by 10%.
“While the mechanism is still not well-explored, it is thought that the stress response by the body to chronic sound exposure causes hormonal imbalances that gradually leads to a permanent elevation of blood pressure,” said Golam Dastageer Prince, MBBS, MPH, medical officer ...
New study finds chronic high caffeine consumption may heighten risk for cardiovascular disease
2024-08-15
From coffee to tea, caffeinated beverages are an integral part of morning routines across the globe, but these popular drinks can be harmful when enjoyed in excess. According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of caffeine per day on most days of the week could increase the susceptibility of otherwise healthy individuals to cardiovascular disease.
“Regular caffeine consumption could disturb the parasympathetic system, leading to elevated blood pressure ...
$1.2 million in federal funding to study women Veterans experiencing homelessness
2024-08-15
A first-of-its-kind study led by Lawson Health Research Institute is receiving $1.2 million in funding from the federal government, delivered through the Veteran Homelessness Program, to better understand homelessness amongst women in Canada who are military Veterans.
“This is an important and yet often invisible problem,” says Dr. Cheryl Forchuk, Lawson Assistant Scientific Director based at St. Joseph’s Health Care London’s Parkwood Institute and the study lead. “This is the first Canadian study to focus exclusively on women Veterans’ experience of homelessness. Gender matters, especially when we’re talking ...
Robot planning tool accounts for human carelessness
2024-08-15
PULLMAN, Wash. -- A new algorithm may make robots safer by making them more aware of human inattentiveness.
In computerized simulations of packaging and assembly lines where humans and robots work together, the algorithm developed to account for human carelessness improved safety by about a maximum of 80% and efficiency by about a maximum of 38% compared to existing methods.
The work is reported in IEEE Transactions on Systems Man and Cybernetics Systems.
“There are a large number of accidents that are happening every day due to carelessness – most of them, unfortunately, from human errors,” said lead ...
deCODE genetics: Rare sequence variants, that associate with a high risk of Parkinson‘s Disease
2024-08-15
Scientists at deCODE genetics, a subsidiary of AMGEN, have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson‘s Disease. The findings also support less studied pathways involved in the pathogenesis of the disease.
The study, published today in npj Parkinson‘s Disease, used whole-genome sequence data from Iceland (deCODE genetics), the UK (UK Biobank), and the US (Accelerating Medicines Partnership Parkinson‘s ...